Chris Nolan

2.9k total citations · 1 hit paper
56 papers, 2.3k citations indexed

About

Chris Nolan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chris Nolan has authored 56 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Chris Nolan's work include Cancer Cells and Metastasis (6 papers), Neuroscience and Neuropharmacology Research (6 papers) and Breast Cancer Treatment Studies (6 papers). Chris Nolan is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Neuroscience and Neuropharmacology Research (6 papers) and Breast Cancer Treatment Studies (6 papers). Chris Nolan collaborates with scholars based in United Kingdom, United States and Nigeria. Chris Nolan's co-authors include E. Margoliash, Geoffrey L. Greene, John Cavanagh, E. V. Jensen, Edmond H. Fischer, David Ray, Emil L. Smith, A. W. Brown, William B. Novoa and Edwin G. Krebs and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Annual Review of Biochemistry.

In The Last Decade

Chris Nolan

56 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monoclonal antibodies to human estrogen receptor.

1980 431 citations Geoffrey L. Greene, Chris Nolan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Nolan United Kingdom	27	938	519	401	333	235	56	2.3k
Randall C. Schatzman United States	29	1.9k 2.0×	310 0.6×	431 1.1×	161 0.5×	121 0.5×	42	4.7k
Jaime Font de Mora Spain	29	1.7k 1.8×	729 1.4×	581 1.4×	462 1.4×	67 0.3×	94	3.1k
Andreas Rolfs United States	26	2.2k 2.3×	399 0.8×	441 1.1×	775 2.3×	167 0.7×	46	5.6k
Hannah Rosenthal United States	16	1.7k 1.8×	616 1.2×	444 1.1×	310 0.9×	175 0.7×	23	3.6k
Reinhard Walther Germany	32	1.8k 1.9×	267 0.5×	229 0.6×	378 1.1×	167 0.7×	97	3.0k
James C. Bartholomew United States	23	1.8k 1.9×	265 0.5×	338 0.8×	340 1.0×	78 0.3×	55	3.1k
Mark A. Polokoff United States	27	2.0k 2.1×	550 1.1×	327 0.8×	277 0.8×	144 0.6×	44	4.1k
James I. Elliott United Kingdom	31	1.9k 2.1×	296 0.6×	499 1.2×	66 0.2×	252 1.1×	71	4.7k
Tokuo Yamamoto Japan	19	1.9k 2.0×	324 0.6×	189 0.5×	472 1.4×	158 0.7×	30	3.0k
Shuichi Sakamoto Japan	29	2.1k 2.2×	166 0.3×	661 1.6×	502 1.5×	155 0.7×	164	3.6k

Countries citing papers authored by Chris Nolan

Since Specialization

Citations

This map shows the geographic impact of Chris Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Nolan more than expected).

Fields of papers citing papers by Chris Nolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Nolan. The network helps show where Chris Nolan may publish in the future.

Co-authorship network of co-authors of Chris Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Nolan. A scholar is included among the top collaborators of Chris Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Nolan. Chris Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilligan, Paddy, et al.. (2018). Provision of MR imaging for patients with cardiac implantable electronic devices (CIEDs): a single-center experience and national survey. Irish Journal of Medical Science (1971 -). 188(3). 999–1004. 6 indexed citations

Johnston, Simon J., Mohammed A. Aleskandarany, Sasagu Kurozumi, et al.. (2018). Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair. BMC Cancer. 18(1). 1027–1027. 1 indexed citations

Banjo, A A, et al.. (2017). Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients. Molecular Diagnosis & Therapy. 22(1). 79–90. 8 indexed citations

Green, Andrew R., Daniele Soria, Des G. Powe, et al.. (2016). Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer. Breast Cancer Research and Treatment. 157(1). 65–75. 22 indexed citations

Aleskandarany, Mohammed A., Daniele Soria, Andrew R. Green, et al.. (2015). Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification. Breast Cancer Research and Treatment. 151(2). 325–333. 21 indexed citations

Rakha, Emad A., Daniele Soria, Andrew R. Green, et al.. (2014). Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer. British Journal of Cancer. 110(7). 1688–1697. 71 indexed citations

Jerjees, Dena, et al.. (2014). ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer. Breast Cancer Research and Treatment. 147(1). 25–37. 15 indexed citations

Anunobi, C C, et al.. (2013). Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women. Pathology - Research and Practice. 210(1). 10–17. 12 indexed citations

Bart, Gavin, Qi Wang, James S. Hodges, Chris Nolan, & Gregory A. Carlson. (2012). Superior methadone treatment outcome in Hmong compared with non-Hmong patients. Journal of Substance Abuse Treatment. 43(3). 269–275. 11 indexed citations

10.

Xu, Jinsheng, Chris Nolan, T. Lister, Wendy M. Purcell, & David Ray. (1999). Pharmacokinetic Factors and Concentration-Time Threshold in m-Dinitrobenzene-Induced Neurotoxicity. Toxicology and Applied Pharmacology. 161(3). 267–273. 8 indexed citations

11.

Glynn, Paul, JL Holton, Chris Nolan, et al.. (1998). Neuropathy target esterase: Immunolocalization to neuronal cell bodies and axons. Neuroscience. 83(1). 295–302. 43 indexed citations

12.

Holton, JL, Chris Nolan, S Burr, David Ray, & John Cavanagh. (1997). Increasing or decreasing nervous activity modulates the severity of the glio-vascular lesions of 1,3-dinitrobenzene in the rat: effects of the tremorgenic pyrethroid, Bifenthrin, and of anaesthesia. Acta Neuropathologica. 93(2). 159–165. 12 indexed citations

13.

Hajimohammadreza, Iradj, Valerie Anderson, John Cavanagh, et al.. (1994). β-amyloid precursor protein fragments and lysosomal dense bodies are found in rat brain neurons after ventricular infusion of leupeptin. Brain Research. 640(1-2). 25–32. 26 indexed citations

14.

Cavanagh, John, Chris Nolan, Malcolm P. Seville, Valerie Anderson, & P. Nigel Leigh. (1993). Routes of excretion of neuronal lysosomal dense bodies after ventricular infusion of leupeptin in the rat: a study using ubiquitin and PGP 9.5 immunocytochemistry. Journal of Neurocytology. 22(9). 779–791. 16 indexed citations

15.

Cavanagh, John, Chris Nolan, & Malcolm P. Seville. (1993). The neurotoxicity of α‐chlorohydrin in rats and mice: I. Evolution of the cellular changes. Neuropathology and Applied Neurobiology. 19(3). 240–252. 32 indexed citations

16.

Seawright, A. A., A. W. Brown, Chris Nolan, & John Cavanagh. (1990). Selective degeneration of cerebellar cortical neurons caused by cycad neurotoxin, L‐β‐methylaminoalanine (L‐BMAA), in rats. Neuropathology and Applied Neurobiology. 16(2). 153–169. 58 indexed citations

17.

Nolan, Chris, A. W. Brown, & John Cavanagh. (1990). Regional variations in nerve cell responses to trimethyltin intoxication in Mongolian gerbils and rats; further evidence for involvement of the Golgi apparatus. Acta Neuropathologica. 81(2). 204–212. 14 indexed citations

18.

Nolan, Chris, J. Gordon Lindsay, Anthony Davies, et al.. (1989). Anatomical mapping of glucose transporter protein and pyruvate dehydrogenase in rat brain: an immunogold study. Brain Research. 499(2). 214–224. 49 indexed citations

19.

Greene, Geoffrey L., et al.. (1988). Purification of T47D Human Progesterone Receptor and Immunochemical Characterization with Monoclonal Antibodies. Molecular Endocrinology. 2(8). 714–726. 66 indexed citations

20.

Steiner, Donald F., Jeffrey L. Clark, Arthur H. Rubenstein, et al.. (1969). 第12回日本糖尿病学会総会記録 (I) 招待講演 II) Biosynthesis and Structure of Proinsulin and Related Products. 12(6). 437–446. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact